WO2002004958A1

WO2002004958A1 - Method for determining potential alterations of a substance having biological activities

Info

Publication number: WO2002004958A1
Application number: PCT/FR2001/002170
Authority: WO
Inventors: Jacques Benveniste; Didier Guillonnet
Original assignee: Digibio
Priority date: 2000-07-12
Filing date: 2001-07-05
Publication date: 2002-01-17
Also published as: FR2811763B1; FR2811763A1; AU2001278525A1

Abstract

The invention concerns a method applied to a substance treated to exhibit a biological activity, for example a coagulating or anticoagulation activity. The treated substance has been obtained, from a source substance having the biological activity, after a treatment such that the treated substance does not contain any molecule of the source substance in significant amount. The treatment may consist in carrying out a high dilution process of the type used for producing homeopathic solutions or granules. The method is designed to diagnose potential alterations of the treated substance by external factors. It comprises the step which consists in: placing a reference substance sample in a zone (19) protected from external influence; subjecting a sample of the treated substance to external influence (20); comparing the results of the tests carried out using a biological control system respectively with the reference substance sample and the treated substance sample. Thus, if the results of the tests are different, the alterations of the treated substance by external influence (20) are demonstrated.

Description

DETERMINING POTENTIAL ALTERATIONS OF A SUBSTANCE HAVING BIOLOGICAL ACTIVITIES

It has been described, in patent No. WO 00/17638 published on March 30, 2000 and having as its title "Method, system and device for producing, from a substance, signals, in particular electrical signals, characteristics of the biological and / or chemical activity of said substance ", which can be treated with a receptor substance, initially having no particular biological activity, in particular water, so that it exhibits after treatment a biological activity. The receiving substance after treatment is hereinafter called the "Treated Substance" (or Informed Matter). When the receiving substance is water, the Treated Substance is called "Treated Water" (or even Informed Water). The substance having biological activity may also be in the form of a homeopathic preparation or granules.

It will be recalled, later in the description of the present invention, how one can produce Informed Water, from a mother substance, in particular a mother substance having an anticoagulant effect such as heparin. This recall will be carried out by reference to patent No. WO 00/17637 published on March 30, 2000 and having as its title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect. Therapeutic applications of said substance or of said signal. "

As described in this same patent No. WO 00/17637, to test a Treated Substance, in particular Informed Water, it is applied to a sensitive biological system to observe its effects. For example, in the case where we test Informed Water having a coagulating or anticoagulant effect, we mix respectively in the following proportions (1/3, 2/3) Informed Water and plasma. Then we measures coagulation times.

Such tests are particularly sensitive to disturbing phenomena. The inventors have surprisingly and unexplainedly observed that certain individuals have an inhibiting or potentiating effect on Informed Water. For example, they only need to approach Informed Water to alter its properties. Other individuals, however, amplify the effects of the properties of Informed Water.

It would be desirable to know, a priori, the individuals having such capacities since, by their presence, they can act in a positive or negative way on the properties of Informed Water. They can therefore compromise the implementation of industrial applications thereof. For example, the transportation and handling, by such people, of Treated Substances constitutes an obstacle (activity is impaired) to the industrial development of these substances. This is the problem posed. How to diagnose people with such inhibition or potentiating effects?

There is no known state of the art proposing a solution to the problem posed. The reason is simple: on the one hand, until the research work of the inventors, it was not known that one could modify the activity of water, on the other hand, one was unaware that phenomena unknown could alter the biological properties of Informed Water from a distance.

The invention relates to a method for diagnosing potential alterations of a substance having biological activities of a source substance no longer present in significant quantity.

The method is applied to a substance exhibiting a biological activity, for example a coagulant or anticoagulant activity. The substance was obtained from a source substance with biological activity, at the end of a treatment such that the substance does not contain a molecule of the source substance in significant quantity (the substance is hereinafter called the treated substance). The treatment may in particular consist in implementing a high dilution process of the same nature as that used to produce homeopathic solutions or granules. The treatment can also in particular consist in implementing the method of Jacques Benveniste, comprising several stages, as described in patent N ° WO 00/17637 published on March 30, 2000 and having for title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect. Therapeutic applications of said substance or of said signal. " It includes the step of transforming the electromagnetic field originating from the source substance having a biological activity, into a signal, in particular an electrical signal, by means of a transducer-receiver capturing the electromagnetic field. The source substance has, for example, an effect on blood clotting and may, for example, contain Ca ⁺⁺ ions or heparin. The method further comprises the step of applying to a receptor substance, initially having no particular biological activity, the signal from the transducer-receiver, by means of a transducer-transmitter. Thus, for example, after the treatment defined above, the receptor substance, initially having no particular biological activity, then exhibits coagulant or anticoagulant activity.

The method is designed to diagnose potential alterations in the substance being treated by external influences and is characterized in that it comprises several stages.

It includes the step of placing a sample of a reference substance in an area sheltered from the external influence being diagnosed.

It also includes the step of subjecting a sample of the substance being treated to the external influence which is the subject of the diagnosis.

H further includes the step of comparing test results carried out by means of a biological control system respectively with the sample of the reference substance and the sample of the treated substance subject to external influence.

Thus, if the results of the tests are different, the potential alterations of the substance treated by the external influence are highlighted.

Preferably, the reference substance is the treated substance.

Preferably, the sample of the reference substance is calibrated by means of the biological control system, in the absence of external influence.

Preferably, to place a sample of the reference substance in an area sheltered from the external influence being diagnosed, it is protected from the effects of electromagnetic fields.

Preferably, to protect the sample of the reference substance from the effects of electromagnetic fields, it is placed in an enclosure surrounded by a magnetic shield made in particular of soft iron or mumetal.

Preferably, the biological control system is characterized in that it reacts, in the presence of the treated substance, in accordance with the biological activity of the source substance.

Preferably, the biological control system is blood or blood plasma.

Preferably, external influences can be induced by people in the vicinity of the substance being treated.

The invention also relates to a system for diagnosing potential alterations of a substance having biological activities of a source substance no longer present in significant quantity.

The system is applied to a substance having biological activity, for example coagulant or anticoagulant activity. The substance was obtained from a source substance with biological activity after processing such that the substance does not contain a molecule of the source substance in a significant amount (the substance is hereinafter called the substance treated). The treatment may in particular consist in implementing a high dilution process of the same nature as that used to produce homeopathic solutions or granules. The treatment can also in particular consist in implementing the method of Jacques Benveniste, comprising several stages, as described in patent N ° WO 00/17637 published on March 30, 2000 and having for title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect. Therapeutic applications of said substance or of said signal. " It includes the step of transforming the electromagnetic field originating from the source substance having a biological activity, into a signal, in particular an electrical signal, by means of a transducer-receiver capturing the electromagnetic field. The source substance has, for example, an effect on blood clotting and may, for example, contain Ca ⁺⁺ ions or heparin. The method further comprises the step of applying to a receptor substance, initially having no particular biological activity, the signal from the transducer-receiver, by means of a transducer-transmitter. Thus, for example, after the treatment defined above, the receptor substance, initially having no particular biological activity, then exhibits coagulant or anticoagulant activity.

The system is designed to diagnose potential alterations in the substance being treated by external influences and is characterized in that it comprises several elements.

H includes a sample of a reference substance placed in an area sheltered from external influence being diagnosed.

It also includes a sample of the treated substance submitted to the external influence that is the subject of the diagnosis.

It also includes a biological control system for carrying out comparative tests respectively with the sample of the reference substance and the sample of the treated substance subjected to external influence.

Preferably, the reference substance is the treated substance.

Preferably, the sample of the reference substance is placed in an area protected from the effects of electromagnetic fields.

Preferably, the sample of the reference substance is placed in an enclosure surrounded by a magnetic shield made in particular of soft iron or mumetal.

Preferably, the biological control system is blood or blood plasma.

Other characteristics and advantages of the invention will appear on reading the description of the variant embodiments given by way of non-limiting example and of FIGS. 1 and 2 presenting a system making it possible to produce "informed water" , from a mother substance having an anticoagulant effect, in particular heparin, of FIG. 3 presenting a schematic view of the method and of the system according to the invention, making it possible to diagnose the potential alterations of "informed water""from a parent substance having an anticoagulant effect, in particular heparin. We will first of all recall how one can produce "informed water", from a mother substance having an anticoagulant effect, in particular heparin. There is shown in Figures 1 and 2 a system according to that described in patent No. WO 00/17637 published March 30, 2000 and having as title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect Therapeutic applications of said substance or signal. " The system makes it possible to produce, from a mother substance, electrical signals, characteristic of its biological activity. In the present case, the parent substance is heparin 1 having an anticoagulant effect. The system comprises a cylindrical enclosure 2, provided with a shielding isolating the enclosure 2 from parasitic fields coming from the environment. The enclosure 2 is closed by a cover 5 also shielded. A transmitter 4 is located inside the enclosure. It generates a determined excitation field of an electromagnetic nature. The transmitter is powered by a generator 7 designed to generate a low frequency signal, in particular square or sinusoidal low frequency signals, pink noise or, advantageously, white noise. As shown, the generator 7 takes the form of a microcomputer 7, provided with a sound card comprising an analog-digital converter. The converter has an output terminal 8. The output terminal 8 of the microcomputer sound card 7 is connected to the input terminal 8a of the transmitter 4, via an amplifier 9. In the enclosure 2 are placed a plastic tank 3 containing 1 ml of heparin as well as a transducer-receiver 6. The transducer-receiver 6 receives the fields resulting from the interaction of the specific excitation field and heparin 1. The transducer-receiver 6 transforms these fields into electrical signals. These electrical signals appear, at the output 10 of the transducer-receiver 6, in the form of a variable potential difference or of an electric current of varying intensity. The electrical signals available at the output 10 of the transducer-receiver 6 are amplified by a preamplifier 11. The electrical signals, after analog-digital conversion, are subject to digital recording. For this purpose, a microcomputer 7a is used, of the same type as the microcomputer 7, comprising an analog-digital converter. The output 10 of the transducer-receiver 6 is connected to the input 10a of the analog-digital converter of the microcomputer 7a, via the preamplifier 11. In addition, as shown in FIG. 2, the system allows to produce "informed water" from the electrical signals obtained as described above. In a plastic tank 14 is placed a receiving substance, initially showing no particular biological activity, in particular water. This tank 14 is arranged in an electromagnetic field radiated by a transducer-transmitter 13, in this case a coil 13. The input terminals 12 of the coil 13 are connected to the output 12a of an analog-digital converter of a microcomputer 15, via an amplifier 16. The microcomputer 15 stores in memory the electrical signals digitized by means of the microcomputer 7. The microcomputer 15 comprising the analog-digital converter is similar to the microcomputer 7, previously described . The analog-to-digital converter produces electrical signals from digital recording. Thus, by applying the electrical signals to the receiving substance, contained in the tank 14, by means of the transducer-transmitter 13, one obtains informed water having an anticoagulant activity. The informed water thus obtained is susceptible of industrial applications, provided that its properties are not altered. As explained in the preamble to the present description, certain individuals have an inhibiting or, conversely, potentiating effect on informed water, in particular when they handle a tube containing informed water. FIG. 3 presents a schematic view of the method and of the system according to the invention, making it possible to diagnose the potential alterations of "informed water". By potential alterations is meant the inhibitory or potentiating effect that an individual can produce on informed water, by manipulating the tube which contains it. A tube 17a and a tube 18a contain informed water with anticoagulant activity. The informed water was previously produced as described above. The tube 17a is placed in an enclosure 19. The enclosure 19 is surrounded by a magnetic shield 19a, made of soft iron or mumetal. Thus, the tube 17a is located sheltered from the potential alterations of the individual 20. The tube 18a is subjected to the influence of the individual 20. To do this, the individual 20 grasps in his hand 20a the tube 18a, for a fixed period, for example thirty seconds.

As described in patent N ° WO 00/17637 published on March 30, 2000 and entitled "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect. Therapeutic applications of said substance or said signal ", a biological control system, consisting of plasma, is used to verify that the water informed from heparin, contained in tubes 17a and 18a, reacts in accordance with the biological activity of heparin. To obtain this confirmation, the plasma is mixed with the water informed in the tubes 17a and 18a, then allowed to incubate for 15 to 20 minutes. The coagulation of the plasma in the tubes 17a and 18a is then measured. If the observed coagulation rates differ, it is deduced therefrom that the individual 20 has altered the properties of the informed water. More precisely, if the coagulation observed in the tube 18a takes place substantially more quickly than in the tube 17a, it is deduced therefrom that the individual has an informed water inhibition capacity. Conversely, if the coagulation observed in the tube 18a takes place significantly more slowly than in tube 17a, it can be deduced therefrom that the individual has a capacity for potentiating informed water.

Claims

claims

1. Method applied to a substance having a biological activity, for example a coagulant or anticoagulant activity; said substance having been obtained, from a source substance (1) having said biological activity, at the end of a treatment such that the substance does not contain a molecule of the source substance (1) in significant quantity (said substance being hereinafter called the treated substance); said treatment can in particular consist in implementing a high dilution process of the same kind as that used to produce homeopathic solutions or granules, said treatment can also in particular consist in implementing the process of Jacques Benveniste comprising the following steps:

the step of transforming the electromagnetic field originating from said source substance (1) having a biological activity,

(for example coming from a source substance having an effect on blood coagulation such as a solution containing in particular Ca * ⁺ ions or heparin), in a signal, in particular an electrical signal, by means of a transducer-receiver (6) sensing said electromagnetic field,

the step of applying said signal from said transducer-receiver (6) to a receiving substance, by means of a transducer-transmitter (13),

(such that, for example, after the above-defined treatment, the initially inactive receptor substance exhibits coagulant or anticoagulant activity); said method being designed to diagnose potential alterations of said substance treated by external influences and being characterized in that it comprises the following steps: - the step of placing a sample of a reference substance in an area sheltered from external influence being the subject of the diagnosis,

- the step of subjecting a sample of said substance treated to the external influence which is the subject of the diagnosis,

the step of comparing the results of the tests carried out by means of a biological control system respectively with the sample of the reference substance and the sample of the treated substance,

(so that if the test results are different, the potential alterations of said substance treated by said external influence are highlighted).

2. Method according to claim 1 such that the reference substance is the treated substance.

3. Method according to any one of claims 1 or 2 such that the sample of the reference substance is calibrated by means of the biological control system, in the absence of said external influence.

4. Method according to any one of claims 1 to 3 such as to place a sample of the reference substance in an area protected from external influence being the subject of the diagnosis,

- it is protected from the effects of electromagnetic fields.

5. Method according to claim 4 such as to protect the sample of the reference substance from the effects of electromagnetic fields

- It is placed in an enclosure (19) surrounded by a magnetic shielding (19a) made in particular of soft iron or mumetal.

6. Method according to any one of claims 1 to 5; said biological control system being characterized in that it reacts, in the presence of the treated substance, in accordance with the biological activity of the source substance.

7. The method of claim 6, such that the biological control system is blood or blood plasma.

8. Method according to any one of claims 1 to 7 such that external influences can be induced by people (20) located near the treated substance.

9. System applied to a substance exhibiting a biological activity, for example a coagulant or anticoagulant activity; said substance having been obtained, from a source substance (1) having said biological activity, at the end of a treatment such that the substance does not contain a molecule of the source substance (1) in significant quantity (said substance being hereinafter called the treated substance); said treatment can in particular consist in implementing a high dilution process of the same kind as that used to produce homeopathic solutions or granules, said treatment can also in particular consist in implementing the process of Jacques Benveniste comprising the following steps:

- the step of transforming the electromagnetic field originating from said source substance (1) having a biological activity,

(for example from a source substance having an effect on blood coagulation such as a solution containing in particular Ca ⁺⁺ ions or heparin), in a signal, in particular an electrical signal, by means of a transducer-receiver (6) sensing said electromagnetic field,

(such that, for example, after the above-defined treatment, the initially inactive receptor substance exhibits coagulant or anticoagulant activity); said system being designed to diagnose potential alterations in said substance treated by external influences and being characterized in that it comprises:

- a sample of a reference substance placed in an area sheltered from external influence which is the subject of the diagnosis,

- a sample of said treated substance subjected to external influence which is the subject of the diagnosis,

- a biological control system to carry out comparative tests respectively with the sample of the reference substance and the sample of the treated substance,

10. The system of claim 9 such that the reference substance is the treated substance.

11. System according to any one of claims 9 or 10 such that the sample of the reference substance is placed in an area protected from the effects of electromagnetic fields.

12. The system of claim 11 such that the sample of the reference substance is placed in an enclosure (19) surrounded by a magnetic shielding (19a) made in particular of soft iron or mumetal.

13. System according to any one of claims 9 to 12; said biological control system being characterized in that it reacts, in the presence of the treated substance, in accordance with the biological activity of the source substance.

14. The system of claim 13, such that the biological control system is blood or blood plasma.